Marc Robillard, PhDChief Executive Officer at Tagworks Pharmaceuticals
Marc Robillard is founder and CEO of Tagworks Pharmaceuticals, a spin-out of Philips Healthcare, originating from its molecular imaging expertise. Tagworks develops and applies in vivo chemistry to improve the efficacy of cancer therapies and to enable novel approaches in companion diagnostics. Prior to spinning out in 2011 he worked at Philips Research on molecular imaging and drug delivery and at Kreatech Diagnostics on microarray detection. Marc obtained his MSc and PhD in bio(in)organic chemistry at, respectively, the University of Groningen and the Leiden Institute of Chemistry, The Netherlands.